Clinical Trial Update: Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study investigating interactions between pitavastatin and ritonavir-boosted darunavir or efavirenz in hyperlipidemia and HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Pitavastatin (Pitavastatin)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: NYU Langone Health | Conditions: Hyperlipidemia, HIV | Phase 1 | Status: COMPLETED | Results posted: 2020-08-11